GLP-1 Receptor Agonists Improve Outcomes in Rheumatoid and Psoriatic Arthritis
GLP-1 receptor agonists (GLP-1 RAs) have been shown to improve patient-reported outcomes in individuals with rheumatoid arthritis and psoriatic arthritis. These findings suggest that GLP-1 RAs may offer beneficial effects beyond their traditional use, enhancing quality of life and symptom management in these inflammatory arthritis conditions.
Rheumatology Advisor·



